Frederic Baribaud

Frederic Baribaud

Company: Bristol Myers Squibb

Job title: Senior Lead - Translational Early Program

Seminars:

Panel Discussion: Using AI-Enhanced Phenotyping to Provide Novel Understanding of IBD Heterogeneity 9:30 am

To what extent will AI reshape the classification of IBD subtypes? What insights does classify IBD subtypes provide into disease heterogeneity? Delving into AI-enhanced phenotyping for tailoring bespoke treatment options Read more

day: AI/Machine Learning Pre-Conference Focus Day

Using Biomarkers to Change our Approach to Early Clinical Development 9:30 am

Proof of concept studies (POC) today are time consuming, costly and deliver undifferentiated therapeutic options for patients mainly because current clinical endpoints lack dynamic range and carry imprecisions Defining complementary molecularly based clinical endpoints with high dynamic ranges and very low intra- and inter-assessor variability would beneficially impact the duration of POC studies Defining complementary…Read more

day: Conference Day Two

Chair’s Opening Remarks 8:55 am

Read more

day: AI/Machine Learning Pre-Conference Focus Day

Chair’s Closing Remarks & End of Pre-Conference Focus Day 5:00 pm

Read more

day: AI/Machine Learning Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.